News
Springer is in the Jazz's starting lineup against the Thunder on Friday. Friday will be Springer's first start of the season and his first start since April 12, 2024 against the Hornets.
Collier (hamstring) has been ruled out for Friday's game against the Thunder. Collier will miss a second straight game due to right hamstring soreness, and he'll look to be available for Sunday's ...
13 analysts have expressed a variety of opinions on Jazz Pharmaceuticals (NASDAQ:JAZZ) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent ...
Amid a broader selloff in the biopharma sector on Wednesday, Jazz Pharmaceuticals (NASDAQ:JAZZ) dropped ~6% after announcing a $145M settlement to resolve certain antitrust claims filed regarding ...
Share price of JAZZ Pharmaceuticals JAZZ hit $102.82 on Tuesday, close to its 52-week low of $99.06. This decline is attributable to the significant downturn in the broader biotech/drug sector due ...
April 8 (Reuters) - Jazz Pharmaceuticals (JAZZ.O), opens new tab said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its ...
A week after reporting a successful phase 3 trial of Sunosi (solriamfetol) in patients with attention-deficit/hyperactivity disorder (ADHD), Axsome Therapeutics has ...
Jazz Pharmaceuticals plc has a 12-month low of $99.06 and a 12-month high of $148.06. The company has a debt-to-equity ratio of 1.46, a current ratio of 4.26 and a quick ratio of 3.74.
Well, scientists have already proven it can be done. And now they’ve developed a new kind of transparent wood that acts like glass but with surprising advantages. Not only is it strong and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results